AP Top Technology News at 9:18 a.m. EST – Yahoo News

0
27

Reuters

Turkish study revises down Sinovac COVID-19 vaccine efficacy to 83.5%

The COVID-19 vaccine developed by China’s Sinovac Biotech has an efficacy of 83.5% based on final results of Phase III trials, Turkish researchers said on Wednesday, a downward revision from a preliminary finding of 91.25%. The final efficacy rate was based on 41 infections, 32 of which had received a placebo, said Murat Akova, head of the Phase III trials conducted in Turkey. «Because there were no important side effects (in the trial)… let alone the fact that this vaccine is being used widely in our country and no side effect was reported, we can say comfortably that it is safe,» said Serhat Unal, member of the government’s advisory Science Council.

Dejar respuesta

Please enter your comment!
Please enter your name here